Belite Bio (BLTE)

Profile

Full Name

Belite Bio, Inc

Ticker Symbol

BLTE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 29, 2022

Indexes

Not included

Website

http://www.belitebio.com

Employees

25

Key Details

Price

$62.00

Market Cap

$2.00B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$1.18(+0.84% YoY)

PE Ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$62.00
BLTE price is $62.00

Price All-time High

$83.66
BLTE price is currently -25.89% below its historical high of $83.66

Price Today Change

-5.14%
BLTE price is down -5.14% today

Price YTD Change

+0.63%
BLTE price is up +0.63% since January 1st

Price 1-year Change

+53.73%
BLTE price is up +53.73% year-on-year

Price 3-year Change

-
BLTE price 3-year change is unknown

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$2.00B
BLTE market capitalization is $2.00 billion

Market Cap 3-year Change

-
BLTE market capitalization 3-year change is unknown

Market Cap All-time High

$2.58B
BLTE market capitalization is currently -22.52% below its historical high of $2.58 billion

Market Cap Sector Rank

83.35%
BLTE market capitalization is higher than 83.35% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+8.35%
BLTE shares outstanding is up +8.35% year-on-year

Shares Outstanding 3-Year Change

-
BLTE shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.51
BLTE beta is 0.51

200-day SMA

$57.82
BLTE price is currently +7.23% above its 200-day simple moving average

50-day SMA

$61.24
BLTE price is currently +1.24% above its 50-day simple moving average

RSI

49.20
BLTE 14-day relative strength index is 49.20

Volume

0.24
BLTE 30-day relative volume is 0.24

ATR

$2.22
BLTE average true range is $2.22

10-day Historical Volatility

26.95%
BLTE 10-day historical volatility is 26.95%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
BLTE annual revenue value is unknown

Revenue Analysts Estimate

-
BLTE annual revenue consensus analysts' forecast is unknown

Revenue 1-year Change

-
BLTE annual revenue 1-year change is unknown

Revenue Sector Rank

-
BLTE annual revenue is unknown

EPS

EPS

-$1.18
BLTE annual earnings per share is -$1.18

EPS Analysts Estimate

-$1.52
BLTE annual earnings per share is currently -22.37% lower than the consensus analysts' forecast

EPS 1-year Change

+0.84%
BLTE annual earnings per share is up +0.84% year-on-year

EPS Sector Rank

52.24%
BLTE annual earnings per share is higher than 52.24% of companies in Healthcare sector

Profit

Gross Profit

-
BLTE annual gross profit value is unknown

Gross Margin

-
BLTE annual gross profit margin value is unknown

Operating Profit

-$40.00M
BLTE annual operating income is -$40.00 million

Operating Margin

-
BLTE annual operating profit margin value is unknown

Net Income

-$36.14M
BLTE annual net profit is -$36.14 million

Net Margin

-
BLTE annual net profit margin value is unknown

Expenses

Total Expenses

$40.00M
BLTE annual total expenses is $40.00 million

Operating Expenses

$40.00M
BLTE annual total operating expenses is $40.00 million

Cost Of Goods Sold

-
BLTE annual cost of goods sold value is unknown

Selling, General & Administrative Expenses

$10.06M
BLTE annual SGA is $10.06 million

Depreciation And Amortization

$449.00K
BLTE annual depreciation & amortization is $449.00 thousand

Interest Expense

$20.00K
BLTE annual interest expense is $20.00 thousand

Income Tax

$6000.00
BLTE annual income tax is $6000.00

EBIT & EBITDA

EBIT

-$36.12M
BLTE annual earnings before interest & taxes is -$36.12 million

EBITDA

-$35.67M
BLTE annual EBITDA is -$35.67 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$152.13M
BLTE annual total assets is $152.13 million

Non Current Assets

$5.06M
BLTE annual long term assets is $5.06 million

Current Assets

$147.07M
BLTE annual total current assets is $147.07 million

Cash And Cash Equivalents

$31.68M
BLTE annual cash & cash equivalents is $31.68 million

Accounts Receivable

-
BLTE annual accounts receivable value is unknown

Inventory

-
BLTE annual inventory value is unknown

Liabilities

Total Liabilities

$6.31M
BLTE annual total liabilities is $6.31 million

Long Term Liabilities

$261.00K
BLTE annual total long term liabilities is $261.00 thousand

Current Liabilities

$6.05M
BLTE annual total current liabilities is $6.05 million

Accounts Payable

-
BLTE annual accounts payable value is unknown

Debt

Total Debt

$537.00K
BLTE annual total debt is $537.00 thousand

Total Debt 1-year Change

-39.39%
BLTE annual total debt is down -39.39% year-on-year

Long Term Debt

$261.00K
BLTE annual long term debt is $261.00 thousand

Short Term Debt

$276.00K
BLTE annual short term debt is $276.00 thousand

Equity & Capital

Shareholders Equity

$145.82M
BLTE annual stockholders equity is $145.82 million

Book Value

$145.82M
BLTE annual book value is $145.82 million

Retained Earnings

-$107.65M
BLTE annual retained earnings is -$107.65 million

Working Capital

$141.02M
BLTE annual working capital is $141.02 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

-$29.23M
BLTE annual cash flow from operations is -$29.23 million

Cash From Operations 1-year Change

+2.02%
BLTE annual cash flow from operations is up +2.02% year-on-year

Cash From Investing

-$110.57M
BLTE annual cash flow from investing activities is -$110.57 million

Cash From Investing 1-year Change

-175411.11%
BLTE annual cash flow from investing activities is down -175411.11% year-on-year

Cash From Financing

$83.59M
BLTE annual cash flow from financing activities is $83.59 million

Cash From Financing 1-year Change

+10.05%
BLTE annual cash flow from financing activities is up +10.05% year-on-year

CAPEX

CAPEX

-
BLTE annual capital expenditures value is unknown

CAPEX 1-year Change

-
BLTE annual capital expenditures 1-year change is unknown

Free Cash Flow

Free Cash Flow

-$29.39M
BLTE annual free cash flow is -$29.39 million

Free Cash Flow 1-year Change

+1.72%
BLTE annual free cash flow is up +1.72% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

-
BLTE annual gross profit margin value is unknown

Operating Margin

-
BLTE annual operating profit margin value is unknown

Net Margin

-
BLTE annual net profit margin value is unknown

ROA & ROE

ROA

-23.76%
BLTE annual return on assets is -23.76%

ROE

-24.79%
BLTE annual return on equity is -24.79%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
BLTE price to earnings ratio value is unknown

PE Ratio Sector Rank

-
BLTE price to earnings ratio is unknown

PB Ratio

PB Ratio

13.73
BLTE price to book ratio is 13.73

PB Ratio Sector Rank

95.4%
BLTE price to book ratio is higher than 95.4% of companies in Healthcare sector

PS Ratio

PS Ratio

-
BLTE price to sales ratio value is unknown

PS Ratio Sector Rank

-
BLTE price to sales ratio is unknown

Enterprise value

Enterprise Value

$1.97B
BLTE enterprise value is $1.97 billion

Enterprise Value Sector Rank

81.8%
BLTE enterprise value is higher than 81.8% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-54.55
BLTE EV/EBITDA is -54.55

EV/EBITDA Sector Rank

2.53%
BLTE EV/EBITDA is higher than 2.53% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

24.31
BLTE annual current ratio is 24.31

Quick Ratio

-
BLTE annual quick ratio value is unknown

Leverage

Debt To Equity

0.00
BLTE annual debt to equity ratio is 0.00

Interest Coverage Ratio

-1805.90
BLTE annual interest coverage ratio is -1805.90

Risk & Stability

Piotroski F-Score

-
BLTE piotroski f-score value is unknown

Altman Z-Score

-
BLTE altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 26, 25 Benchmark
Buy
Mar 18, 25 HC Wainwright & Co.
Buy
Mar 18, 25 Cantor Fitzgerald
Overweight
Jan 21, 25 Benchmark
Buy
Nov 15, 24 Maxim Group
Buy
Nov 13, 24 HC Wainwright & Co.
Buy
Sep 12, 24 HC Wainwright & Co.
Buy
Aug 13, 24 HC Wainwright & Co.
Buy
Aug 13, 24 Benchmark
Buy
Jun 20, 24 Cantor Fitzgerald
Overweight

Institutional Ownership

Similar stocks

LIVN logo
LivaNova (LIVN)
SEM logo
Select Medical Holdings (SEM)
APGE logo
Apogee Therapeutics (APGE)
LGND logo
Ligand Pharmaceuticals Incorporated (LGND)
BHC logo
Bausch Health Companies (BHC)
MIRM logo
Mirum Pharmaceuticals (MIRM)
Ascentage Pharma Group International (AAPG)
WRBY logo
Warby Parker (WRBY)
ENOV logo
Enovis (ENOV)
  • What is the ticker symbol for Belite Bio?
  • Does Belite Bio pay dividends?
  • What sector is Belite Bio in?
  • What industry is Belite Bio in?
  • What country is Belite Bio based in?
  • When did Belite Bio go public?
  • Is Belite Bio in the S&P 500?
  • Is Belite Bio in the NASDAQ 100?
  • Is Belite Bio in the Dow Jones?
  • When was Belite Bio's last earnings report?
  • When does Belite Bio report earnings?
  • Should I buy Belite Bio stock now?

What is the ticker symbol for Belite Bio?

The ticker symbol for Belite Bio is NASDAQ:BLTE

Does Belite Bio pay dividends?

No, Belite Bio does not pay dividends

What sector is Belite Bio in?

Belite Bio is in the Healthcare sector

What industry is Belite Bio in?

Belite Bio is in the Biotechnology industry

What country is Belite Bio based in?

Belite Bio is headquartered in United States

When did Belite Bio go public?

Belite Bio's initial public offering (IPO) was on April 29, 2022

Is Belite Bio in the S&P 500?

No, Belite Bio is not included in the S&P 500 index

Is Belite Bio in the NASDAQ 100?

No, Belite Bio is not included in the NASDAQ 100 index

Is Belite Bio in the Dow Jones?

No, Belite Bio is not included in the Dow Jones index

When was Belite Bio's last earnings report?

Belite Bio's most recent earnings report was on Mar 17, 2025

When does Belite Bio report earnings?

The next expected earnings date for Belite Bio is May 14, 2025

Should I buy Belite Bio stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page